SCHEMBL7960098

SCHEMBL7960098

COc1ccccc1C(O)C1CCCCC1=O

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.47
ALDH1A1 P00352 3/20 0.46
CHRM2 P08172 1/20 0.43
CHRM4 P08173 1/20 0.43
CHRM5 P08912 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43
CA1 P00915 3/20 0.42
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
MCL1 Q07820 1/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7957428 0.89 ALDH1A1 (0.43) MAPTALDH1A1CHRM2CHRM4CHRM5
SCHEMBL6678097 0.81 ALDH1A1 (0.44) MAPTALDH1A1CHRM2CHRM4CHRM5
SCHEMBL13254537 0.79 CA1 (0.51) MAPTALDH1A1CA1LMNAPOLB
SCHEMBL3486328 0.79 CA1 (0.51) MAPTALDH1A1CA1LMNAPOLB
SCHEMBL29065860 0.78 CA1 (0.66) MAPTALDH1A1CA1LMNASMN1; SMN2
SCHEMBL28652339 0.76 MAPT (0.46) MAPTALDH1A1CA1LMNAPOLB
SCHEMBL7959988 0.76 MAPT (0.52) MAPTALDH1A1USP2LMNAPOLB
SCHEMBL7959844 0.76 MAPK1 (0.45) MAPTALDH1A1USP2LMNAPOLB
SCHEMBL27204450 0.76 ALDH1A1 (0.45) MAPTALDH1A1CA1POLBKDM4E
SCHEMBL14292595 0.76 ALDH1A1 (0.45) MAPTALDH1A1CA1POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6245790-B1 ANTIINFLAMMATORY AGENTS; GASTROINTESTINAL DISORDERS; SKN DISORDERS; BONE DISORDERS; MUSCLE RELAXANTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-06-12 US disclosed
EP-0989975-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-05 EP disclosed
WO-2000016760-A2 NEW USE OF PROSTAGLANDIN E2 ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-03-30 WO disclosed
WO-1998055468-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-10 WO disclosed